174 related articles for article (PubMed ID: 3220097)
21. Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients.
Brass EP
Clin Ther; 1995; 17(2):176-85; discussion 175. PubMed ID: 7614519
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
[TBL] [Abstract][Full Text] [Related]
24. Imipramine disposition in users of oral contraceptive steroids.
Abernethy DR; Greenblatt DJ; Shader RI
Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
26. Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers.
Sahajwalla CG; Helton ED; Purich ED; Hoppel CL; Cabana BE
J Pharm Sci; 1995 May; 84(5):627-33. PubMed ID: 7658356
[TBL] [Abstract][Full Text] [Related]
27. The effect of oral L-carnitine supplementation on the muscle and plasma concentrations in the Thoroughbred horse.
Foster CV; Harris RC; Snow DH
Comp Biochem Physiol A Comp Physiol; 1988; 91(4):827-35. PubMed ID: 2907450
[TBL] [Abstract][Full Text] [Related]
28. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
29. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects.
Hassan-Alin M; Andersson T; Bredberg E; Röhss K
Eur J Clin Pharmacol; 2000 Dec; 56(9-10):665-70. PubMed ID: 11214773
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of pipemidic acid in chickens after single intravenous and oral dosings.
Anadón A; Martínez-Larrañaga MR; Díaz MJ; Vélez C; Bringas P
Am J Vet Res; 1990 Nov; 51(11):1756-9. PubMed ID: 2240801
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of eltoprazine in healthy male subjects after single dose oral and intravenous administration.
Raghoebar M; Mak M; Cournot A; Pistorius MC; Van Harten J; Roseboom H
Br J Clin Pharmacol; 1990 Dec; 30(6):879-83. PubMed ID: 2288834
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and safety of l-carnitine infused i.v. in healthy subjects.
Uematsu T; Itaya T; Nishimoto M; Takiguchi Y; Mizuno A; Nakashima M; Yoshinobu K; Hasebe T
Eur J Clin Pharmacol; 1988; 34(2):213-6. PubMed ID: 3383994
[TBL] [Abstract][Full Text] [Related]
34. The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man.
Dawson M; Braithwaite PA; Roberts MS; Watson TR
Br J Clin Pharmacol; 1985 Jan; 19(1):79-86. PubMed ID: 3978023
[TBL] [Abstract][Full Text] [Related]
35. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of bambuterol in healthy subjects.
Nyberg L; Rosenborg J; Weibull E; Jönsson S; Kennedy BM; Nilsson M
Br J Clin Pharmacol; 1998 May; 45(5):471-8. PubMed ID: 9643620
[TBL] [Abstract][Full Text] [Related]
37. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.
Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G
Eur J Clin Pharmacol; 1980 May; 17(5):385-91. PubMed ID: 7418717
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of xamoterol after intravenous and oral administration to volunteers.
Bastain W; Boyce MJ; Stafford LE; Morton PB; Clarke DA; Marlow HF
Eur J Clin Pharmacol; 1988; 34(5):469-73. PubMed ID: 2904884
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of cotinine after oral and intravenous administration to man.
De Schepper PJ; Van Hecken A; Daenens P; Van Rossum JM
Eur J Clin Pharmacol; 1987; 31(5):583-8. PubMed ID: 3830243
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.
Suzuki A; Sakai Y; Hashimoto K; Osawa H; Tsuruoka S
Ren Fail; 2018 Nov; 40(1):196-200. PubMed ID: 29616582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
